Cardiomyocyte NF-κB p65 promotes adverse remodelling, apoptosis, and endoplasmic reticulum stress in heart failure

Cardiovascular Research

Volumn 89, Issue 1, 2011, Pages 129-138

  Hamid, Tariq ^a   Guo, Shang Z ^a   Kingery, Justin R ^a   Xiang, Xilin ^a   Dawn, Buddhadeb ^b   Prabhu, Sumanth D ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Cardiac remodelling; ER stress; Heart failure; NF B

Indexed keywords

ALANINE; CHAPERONE; CYTOKINE; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SERINE; TRANSCRIPTION FACTOR RELA;

ADAPTATION; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE EXACERBATION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; HEART DILATATION; HEART DISEASE; HEART FAILURE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; LUNG CONGESTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SHAM PROCEDURE; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CELL LINE; CYTOKINES; ENDOPLASMIC RETICULUM; FIBROSIS; HEART FAILURE; HUMANS; I-KAPPA B PROTEINS; INFLAMMATION MEDIATORS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUTANT PROTEINS; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; STRESS, PHYSIOLOGICAL; TRANSCRIPTION FACTOR RELA; VENTRICULAR REMODELING;

EID: 78650443223     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq274     Document Type: Article

References (34)

1. Kumar A, Takada Y, Boriek AM, Aggarwal BB. Nuclear factor-kB: its role in health and disease. J Mol Med 2004;82:434-448.
2. Chen LF, Greene WC. Shaping the nuclear action of NF-kB. Nat Rev Mol Cell Biol 2004;5:392-401.
3. Luo JL, Kamata H, Karin M. IKK/NF-kB signaling: balancing life and death-a new approach to cancer therapy. J Clin Invest 2005;115:2625-2632.
4. Xu C, Bailly-Maitre B, Reed JC. Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest 2005;115:2656-2664.
5. Hayden MS, Ghosh S. Signaling to NF-kB. Genes Dev 2004;18:2195-2224.
6. Driessler F, Venstrom K, Sabat R, Asadullah K, Schottelius AJ. Molecular mechanisms of interleukin-10-mediated inhibition of NF-kB activity: a role for p50. Clin Exp Immunol 2004;135:64-73.
7. Zhong H, May MJ, Jimi E, Ghosh S. The phosphorylation status of nuclear NF-kB determines its association with CBP/p300 or HDAC-1. Mol Cell 2002;9:625-636.
8. Mann DL. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 2002;91:988-998.
9. Prabhu SD, Chandrasekar B, Murray DR, Freeman GL. b-Adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. Circulation 2000;101:2103-2109.
10. Wong SC, Fukuchi M, Melnyk P, Rodger I, Giaid A. Induction of cyclooxygenase-2 and activation of nuclear factor-kB in myocardium of patients with congestive heart failure. Circulation 1998;98:100-103.
11. Grabellus F, Levkau B, Sokoll A, Welp H, Schmid C, Deng MC et al.Reversible activation of nuclear factor-kB in human end-stage heart failure after left ventricular mechanical support. Cardiovasc Res 2002;53:124-130.
12. Frantz S, Stoerk S, Ok S, Wagner H, Angermann CE, Ertl G et al.Effect of chronic heart failure on nuclear factor kB in peripheral leukocytes. Am J Cardiol 2004;94: 671-673.
13. Frantz S, Hu K, Bayer B, Gerondakis S, Strotmann J, Adamek A et al.Absence of NF-kB subunit p50 improves heart failure after myocardial infarction. FASEB J 2006; 20:1918-1920.
14. Kawano S, Kubota T, Monden Y, Tsutsumi T, Inoue T, Kawamura N et al.Blockade of NF-kB improves cardiac function and survival after myocardial infarction. Am J Physiol Heart Circ Physiol 2006;291:H1337-H1344.
15. Timmers L, van Keulen JK, Hoefer IE, Meijs MF, van Middelaar B, den Ouden K et al.Targeted deletion of nuclear factor kB p50 enhances cardiac remodeling and dysfunction following myocardial infarction. Circ Res 2009;104:699-706.
16. Dawn B, Xuan YT, Marian M, Flaherty MP, Murphree SS, Smith TL et al.Cardiac-specific abrogation of NF-kB activation in mice by transdominant expression of a mutant IkBa. J Mol Cell Cardiol 2001;33:161-173.
17. Huxford T, Malek S, Ghosh G. Structure and mechanism in NF-kB/IkB signaling. Cold Spring Harb Symp Quant Biol 1999;64:533-540.
18. Hamid T, Gu Y, Ortines RV, Bhattacharya C, Wang G, Xuan YT et al.Divergent tumor necrosis factor receptor-related remodeling responses in heart failure: role of nuclear factor-kB and inflammatory activation. Circulation 2009;119:1386-1397.
19. Wang G, Hamid T, Keith RJ, Zhou G, Partridge CR, Xiang X et al.Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation 2010; 121:1912-1925.
20. Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, Yagita H et al.Differential regulation of IkB kinase a and b by two upstream kinases, NF-kB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc Natl Acad Sci USA 1998; 95:3537-3542.
21. Luo J, Hill BG, Gu Y, Cai J, Srivastava S, Bhatnagar A et al.Mechanisms of acrolein-induced myocardial dysfunction: implications for environmental and endogenous aldehyde exposure. Am J Physiol Heart Circ Physiol 2007;293: H3673-H3684.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDCT method. Methods 2001;25:402-408.
23. Prabhu SD, Wang G, Luo J, Gu Y, Ping P, Chandrasekar B. b-Adrenergic receptor blockade modulates Bcl-XS expression and reduces apoptosis in failing myocardium. J Mol Cell Cardiol 2003;35:483-493.
24. Baldwin AS. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kB. J Clin Invest 2001;107:241-246.
25. Ravi R, Bedi GC, Engstrom LW, Zeng Q, Mookerjee B, Gelinas C et al.Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-kB. Nat Cell Biol 2001;3:409-416.
26. Purcell NH, Molkentin JD. Is nuclear factor-kB an attractive therapeutic target for treating cardiac hypertrophy? Circulation 2003;108:638-640.
27. Frantz S, Tillmanns J, Kuhlencordt PJ, Schmidt I, Adamek A, Dienesch C et al.Tissue-specific effects of the nuclear factor kB subunit p50 on myocardial ischemia-reperfusion injury. Am J Pathol 2007;171:507-512.
28. Hikoso S, Yamaguchi O, Nakano Y, Takeda T, Omiya S, Mizote I et al.The IkB kinase b/nuclear factor kB signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression. Circ Res 2009;105:70-79.
29. Kratsios P, Huth M, Temmerman L, Salimova E, Al Banchaabouchi M, Sgoifo A et al.Antioxidant amelioration of dilated cardiomyopathy caused by conditional deletion of NEMO/IKKg in cardiomyocytes. Circ Res 2010;106:133-144.
30. Chariot A. The NF-kB-independent functions of IKK subunits in immunity and cancer. Trends Cell Biol 2009;19:404-413.
31. Purcell NH, Tang G, Yu C, Mercurio F, DiDonato JA, Lin A. Activation of NF-kB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes. Proc Natl Acad Sci USA 2001;98:6668-6673.
32. Okada K, Minamino T, Tsukamoto Y, Liao Y, Tsukamoto O, Takashima S et al.Prolonged endoplasmic reticulum stress in hypertrophic and failing heart after aortic constriction: possible contribution of endoplasmic reticulum stress to cardiac myocyte apoptosis. Circulation 2004;110:705-712.
33. Szegezdi E, Logue SE, Gorman AM, Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 2006;7:880-885.
34. Tonnesen MF, Grunnet LG, Friberg J, Cardozo AK, Billestrup N, Eizirik DL et al.Inhibition of nuclear factor- kB or Bax prevents endoplasmic reticulum stress-but not nitric oxide-mediated apoptosis in INS-1E cells. Endocrinology 2009;150: 4094-4103.